Coculture of hepatocytes with islets

Area of Science:

• Hepatology
• Regenerative Medicine
• Bioengineering

Background:

• Bioartificial liver support (BAL) systems offer potential therapeutic solutions for liver failure, aiming to bridge patients to organ transplantation.
• Maintaining hepatocyte viability and function is critical for the efficacy of BAL systems.
• The role of co-cultured islets in supporting hepatocyte health within BAL systems remains an area for investigation.

Purpose of the Study:

• To investigate the impact of co-culturing mouse islets with hepatocytes on hepatocyte viability, function, and apoptosis.
• To assess the potential of an islet-hepatocyte co-culture system for developing advanced BAL devices.

Main Methods:

• BALB/c mouse islets were co-cultured with C57BL/6J hepatocytes.
• Hepatocyte viability, albumin secretion, and apoptosis were assessed over a 7-day culture period.
• Quantitative analysis was performed to compare apoptosis phenotypes between isolated hepatocytes and co-cultured hepatocytes.

Main Results:

• Hepatocyte viability decreased in both isolated and co-cultured groups, but isolated hepatocytes showed increased necrosis and reduced albumin secretion.
• Co-cultured hepatocytes maintained albumin secretion significantly better than isolated hepatocytes by day 7.
• Apoptosis was delayed in the co-cultured group, with both early and late apoptotic phenotypes showing a delayed onset compared to isolated hepatocytes.

Conclusions:

• Co-culturing islets with hepatocytes in a BAL system can preserve hepatocyte function and delay apoptosis.
• This islet-hepatocyte co-culture strategy shows promise for the development of high-performance bioartificial liver support systems.
• Further research into these co-culture systems could lead to improved therapeutic options for liver disease.